<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">338420</id>
  <title nil="true"/>
  <common-name>S-[5-[5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-(2-methoxyanilino)ethanethioate</common-name>
  <description>S-[5-[5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-(2-methoxyanilino)ethanethioate is a chemical compound with the formula C24H20N6O3S2. With an average molecular weight of 504.60 g/mol, S-[5-[5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-(2-methoxyanilino)ethanethioate is a heavy molecule.</description>
  <cas>127248-81-1</cas>
  <pubchem-id>135554543</pubchem-id>
  <chemical-formula>C24H20N6O3S2</chemical-formula>
  <weight>504.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T21:31:28Z</created-at>
  <updated-at type="dateTime">2026-08-30T21:31:28Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC=CC=C3OC)O)C=C4C=NC5=CC=CC=C54</moldb-smiles>
  <moldb-formula>C24H20N6O3S2</moldb-formula>
  <moldb-inchi>InChI=1S/C24H20N6O3S2/c1-14-27-19(11-15-12-25-17-8-4-3-7-16(15)17)22(32)30(14)23-28-29-24(35-23)34-21(31)13-26-18-9-5-6-10-20(18)33-2/h3-12,26,32H,13H2,1-2H3/b15-11+</moldb-inchi>
  <moldb-inchikey>PVWOBVIBBKBNSN-RVDMUPIBSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">504.1038309</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM334313</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>S-[5-[5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-(2-methoxyanilino)ethanethioate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom nil="true"/>
  <superklass nil="true"/>
  <klass nil="true"/>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0288847</sync-id>
  <structure-inchikey>PVWOBVIBBKBNSN-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20088000000008000000000020000000000000040000004000000040080000000000000080004020000000200000008000200000000000080400010000800000000800000000000000200000100003000000000000000001000000000100300000400000080000040000040001008001000000800100000000000000400000008000000000000020800800000001000000804000000000000000000000000000000000000800000022800004800000000000040000a0000080000000000000006000000000000000040000008000082000000200000000000000000000000001000040000000010400000000000020000040000000020000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:12Z</structure-indexed-at>
</compound>
